In this work, the NRTL-SAC and the Pharma UNIFAC models are evaluated with respect to the capability of prediction of solid-liquid equilibria of pharmaceutical compounds in organic solvents. The original NRTL-SAC model is extended through the introduction of temperaturedependent binary interaction parameters, and the two versions of the model are parametrized using VLE data. The performance of the NRTL-SAC models for correlation and prediction of the 2 solubility of eight medium-sized flexible pharmaceutical or pharmaceutically similar molecules in multiple pure, organic solvents is examined: risperidone, fenofibrate, fenoxycarb, tolbutamide, meglumine, butyl paraben, butamben and salicylamide. The performance of the Pharma UNIFAC model is evaluated using data for six of these compounds. In general, it is found that introducing a dependence on temperature to the binary interaction parameters of the NRTL-SAC model can improve its capability for modeling and prediction of the solubility of active pharmaceutical ingredients. For prediction of solubility data the Pharma UNIFAC model generally performs below the two NRTL-SAC models. Averaged over all evaluated systems where the solubility was predicted with each method, the root mean squared logarithmic error in predicted mole fraction solubility obtained for Pharma UNIFAC (30 systems) and for the original and the modified temperature-dependent forms of the NRTL-SAC model (29 systems) are 1.64, 1.17 and 1.09, respectively. Comparing only those systems for which all models were evaluated (18 systems), the RMSLE values are 1.42, 1.06 and 0.87, respectively.
Introduction
Experimental determination of solid-liquid solubility can be a costly and tedious process, and accurate methods for prediction are in high demand. The basis for the vast majority of solubility models is the separation of the ideal component, the activity of the solute, which at equilibrium is equal to the activity of the pure solid, a s , from the activity coefficient in the saturated solution, γ sat .
In logarithmic notation: 
where xsat denotes mole fraction solubility. Within a Raoult's law framework, the activity of the pure solid is most conveniently defined with the pure liquid phase at the same temperature, in effect a supercooled melt, as the thermodynamic reference state. 1 Thus, for an ideal solution the activity coefficient equals unity and the solubility equals the activity of the solid.
For accurate prediction of the mole fraction solubility, it is necessary to estimate both the activity of the solid phase and the activity coefficient in the saturated solution. The activity of the pure solid can be expressed as: (2) where ∆ fus H (Tm) denotes the heat of fusion at the melting point, R the universal gas constant, and ∆Cp the difference in heat capacity between the supercooled melt and the solid. The heat capacity terms in eq 2 are often neglected, but it has been shown in several studies [3] [4] [5] [6] that this practice can lead to a substantial error, at least for molecules with conformational flexibility and relatively high melting points, such as most pharmaceuticals.
Numerous models for the correlation and prediction of solution activity coefficients within a Raoult's law framework have been proposed in the literature. These can be divided into three classes: correlative models including the Wilson, 7 UNIQUAC 8 and NRTL 9 models; predictive models such as UNIFAC 10 and its modifications, COSMO-RS 11 and COSMO-SAC; 12 and semipredictive models like NRTL-SAC. 13 So far, no model has been shown to be capable of predicting the solubility of pharmaceutical compounds with an accuracy sufficient for process design, i.e. at least in the order of ± 15% for calculations of yield and productivity, and -because crystallization kinetics depend strongly on the supersaturation -in the order of ± 1% for estimation of crystallization driving forces and prediction of product crystal size distributions.
Correlative models are chiefly fitted to experimental data for the determination of a parameter set to be used for a given system. Mirmehrabi et al. 14 used a group contribution method to obtain parameters associated with UNIQUAC and utilized two adjustable parameters to model solubility data of two polymorphs of ranitidine hydrochloride. The average relative deviation (ARD) error of solubility correlation in their work was reported to be between 0.89% -3.53% for two forms of ranitidine hydrochloride in different solvents. The NRTL model, using two adjustable parameters, 15 has been used to correlate the solubility of niflumic acid, flufenamic acid and diclofenac sodium in different solvents. The authors report deviations between correlated and experimental temperature to be in range 1 -3 K, which corresponds to an ARD of approx. 2% in solubility.
For the attempted prediction of the solubility of drugs, the COSMO-RS and COSMO-SAC models have been used extensively. Mullins et al. 16 report root mean squared logarithmic errors (RMSLE) in mole fraction solubility ranging between 1.6 and 3.26 for these methods. However, they suffer from being computationally expensive. 
Modeling work

Pharmaceutical model compounds
The eight model compounds used in this evaluation are shown in Figure 1 . All are medium-sized organic molecules with some conformational flexibility and with polar, non-polar and hydrogenbonding functionality. Furthermore, all are either pharmaceutical compounds or chemically similar. For all these compounds, melting points, heats of fusion and heat capacities of both the solid and the supercooled melt have previously been experimentally determined. This allows the activity of the pure solid (eq 2), and thereby the activity coefficients at saturation (eq 1), to be determined with comparatively high accuracy. Calorimetric data are given in Table 1 . In case the compound has several known polymorphs, data for the stable form has been used. For the enantiotropic compound tolbutamide, the hightemperature form was used. For data determined within our group, 95% confidence intervals are specified. For salicylamide, the tabulated heat capacity coefficients are based on data determined in-house according to the same procedure as for the other compounds. Details are given in the supporting information. The data for butamben has not yet been published. In all cases, ΔCp is well correlated by a linear equation of two parameters, A and B: The NRTL-SAC model The activity coefficient is the sum of two terms, the combinatorial and residual contributions:
The combinatorial term, adapted from Flory-Huggins theory, is entropic in nature and accounts 
The complete set of equations pertaining to the NRTL-SAC model is reported by Chen and Song. 13 In the above equations r denotes segment numbers, and α is the NRTL non-random parameter.
The value of α in this work is set to 0. In its original form, the NRTL-SAC model assumes segment interaction parameters τ and segment numbers r to be independent of temperature. However, for the NRTL model 9, 34 it is well-known that the interaction parameters have to be given a temperature-dependence in order to be able to describe equilibria covering any significant temperature range. In this work, an extended NRTL-SAC model has been evaluated, in which the interaction energy parameters are given a simple inverse dependence on the absolute temperature according to:
where bij is a temperature-independent parameter representing the interaction energy between segments i and j. There are 12 possible binary, direction-dependent interaction parameters between different segment types, to be determined using binary VLE equilibrium data for a small number of reference solvents: in this work, like in the original publication, 13 (for the temperature-dependent NRTL-SAC model.) This leaves 6 interaction parameters to be determined using data for the reference solvents. For each solvent for which the model is to be used (solvent as distinguished from reference solvent) there are four segment numbers that have to be determined using binary equilibrium data between the particular solvent and each of the reference solvents. For each solute there are also four segment numbers that are determined using solid-liquid solubility data in a selected number of solvents and/or reference solvents.
In order to allow a comparison between the two functional forms of the NRTL-SAC model to be made, the parameters of both the original and the temperature-dependent models have been determined using the same data. Throughout this work, the two versions of the model together with the parameters determined here are referred to as NRTL-SAC(O) and NRTL-SAC(T),
respectively. The objective function used for fitting binary interaction parameters and segment numbers of both NRTL-SAC models is:
where γ exp is the experimentally determined activity coefficient, γ model is the activity coefficient calculated using NRTL-SAC, N is the number of data points and C is the component. 
where τij(298 K) denotes the binary interaction parameter at 298 K reported in the original NRTL-SAC publication. 13 In the second step, segment numbers for the 8 solvents used for the solid-liquid equilibria: 1-butanol, 1-propanol, 2-propanol, acetone, ethanol, ethyl acetate, methanol and toluene, have been determined for both NRTL-SAC models, using VLE data taken from the DECHEMA vapor-liquid data collection. 35 Data for 24 binary mixtures in total has been used, with each system consisting of a solvent and one of the three reference solvents. Segment numbers for the three reference solvents were taken from the original NRTL-SAC publication. Finally, in the third step, segment numbers for the eight pharmaceutical solutes have been determined through correlation of experimental solubility data in two different solvents for each compound. For this purpose, the activity of the pure solid (stable polymorph) was obtained using eq 2, with ∆Cp modeled by eq 3. Activity coefficients could then be calculated from experimentally reported solubilities (of the stable polymorph) using eq 1.
For the parameter determination for each solute, one polar solvent (methanol) and one non-polar solvent (toluene, or lacking solubility data, the least polar solvent available) were selected in order to capture polarity-related characteristics of the solutes. Ideally, of course, three or four solvents rather than two should be chosen for parameter determination -selected to capture hydrophilic, polar attractive and repulsive, and hydrophobic interactions. However, in many such would-be suitable solvents the solubility is poor, and thus has not been of general interest. Consequently, due to a lack of experimentally available solubility data for the solute compounds, it was not possible to find suitable data in more solvents. Reported experimental solubility data in methanol and toluene was used for risperidone, 25 fenoxycarb, 27 tolbutamide 30 and butamben (unpublished work), while solubility data in methanol and ethyl acetate was used for fenofibrate, 26 butyl paraben 36 and salicylamide, 33 and solubility data in methanol and 2-propanol was used for meglumine. 31 Temperature ranges are given in Table 5 . Table 2 shows the binary interaction parameters between segments obtained for the two NRTL-SAC models. The binary interaction parameters between segments Y -and Y + were set to zero as in the original model. 13 Segment numbers (rX, rY-, rY+ and rZ) for each of the solvents and solutes are listed in Table 3 . Table 3 . Segment numbers of solvents and solutes for the two NRTL-SAC models. 
NRTL-SAC(O) NRTL-SAC(T) Compound
Results and discussion
Comparison of functional forms of the NRTL-SAC model for correlation of VLE data
The difference between experimental activity coefficients and activity coefficients, calculated with the two respective NRTL-SAC models for each component of 26 binary mixtures using the parameters given in Tables 2 and 3 , has been quantified using the average relative deviation, Table 4 .
Although there are individual cases in Table 4 where NRTL-SAC(O) results in a lower ARD than the temperature-dependent model, the overall average ARD, taken over all γ1 + γ2 values in Table   4 , is lower for NRTL-SAC(T) (0.16) than for NRTL-SAC(O) (0.19). Considering each of the solvents in binary mixtures with each of the three reference solvents, as in the determination of the segment parameters, and averaging the ARD of γ1 + γ2 over three binary systems for each solvent, results in values plotted in Figure 2 . The introduction of a temperaturedependent binary interaction parameter improves the performance of the NRTL-SAC model for all the solvents, with the exception of 2-propanol for which the ARD is unchanged. Overall, it can be stated with certainty that the introduction of a temperature-dependent binary interaction parameter to this model leads to a measurable, although modest, improvement in the correlation of VLE data. Table 4 . Average relative deviation (ARD) in activity coefficients for the two NRTL-SAC models. 
T-range ARD
NRTL-SAC(O) NRTL-SAC(T)
Comparison of all three models for prediction of solid-liquid solubility
In Table 5 the root mean squared logarithmic error (RMSLE) in calculated vs. experimental mole fraction solubility, eq 14, for each of the solute -solvent systems are listed for each of the evaluated methods. Solvents used for parameter determination, and for which, consequently, the listed errors refer to data correlation rather than prediction, are marked with an asterisk (*).
In Figure Table 5 . Table 5 . RMSLE in predicted mole fraction solubility for the three models. An asterisk (*)
indicates that the solvent was used in the parameter determination.
RMSLE
Compound Solvent N T-range (K)
Pharma UNIFAC
NRTL-SAC(O) NRTL-SAC(T)
Risperidone As can be seen in Figure 3 and Table 5 , overall the NRTL-SAC models perform better than Pharma UNIFAC. In only 5 out of 30 systems where all three models could be evaluated Pharma UNIFAC results in the lowest prediction error. Out of the remaining 25 systems (13 of which constitute predictions rather than correlations for the NRTL-SAC models) one (5 cases) or both (20 cases) of the NRTL-SAC models perform better than Pharma UNIFAC. Averaged over all solvents, for each compound either of the NRTL-SAC models results in the lowest overall error.
All methods perform best overall for butyl paraben, and this is also the compound for which the Pharma UNIFAC method comes closest in performance relative to the two NRTL-SAC models.
For solubility prediction of this compound, each method performs better than the others in at least one solvent each. In Figure 4 , the experimental solubility of butyl paraben in four solvents is compared with solubility curves predicted using the three models. In acetonitrile, the Pharma It should be noted in this context that the RMSLE errors are similar in magnitude as the expected size of the contribution to the activity from the heat capacity terms in eq 2 for pharmaceutical molecules. For the compounds in this work, the activity of the solid (ideal solubility), and thus the activity coefficient in all solvents, was found to decrease by between 3% -86% (36% on average over all 8 compounds) when disregarding the contribution from ∆Cp. This corresponds to an RMSLE value of 0.93 calculated over all 8 compounds. This points to the importance of not neglecting the heat capacity in the modelling of the activity of the solid when predicting solubility.
Looking at all the systems in Table 5 , the temperature-dependent model scores better in 29 out of 45 cases, including all fenoxycarb systems. In Figure 3 , with the notable exception of one outlier (risperidone in acetone), there is a visible trend of data points comparing the two NRTL-SAC methods being shifted to the right of the diagonal. Overall, this shows that, as a general expectation, the introduction of a simple inverse temperature-dependence to the binary interaction parameters of the NRTL-SAC model does lead to a modestly improved accuracy in the prediction of the solubility of pharmaceutical compounds.
The worst prediction results overall were obtained for risperidone. This molecule is arguably the most complex one out of the eight pharmaceutical compounds evaluated. Conversely, butyl paraben and butamben, two much less complex molecules, resulted in the overall best predictions.
The simplest indicator of the complexity of a molecule is its molecular weight. Figure 5 shows a breakdown of RMSLE values for each compound, averaged over all the solvents (a) as well as for only the solvents where actual prediction was performed for the NRTL-SAC models (b), for the three evaluated models. As can be seen in Figure 5 b, for the NRTL-SAC models there is a tendency towards increased prediction error for substances with increasing molecular weight.
Salicylamide, the only compound for which the solubility in water was included in the evaluation, constitutes a clear exception to this trend. It is notable that the prediction results for this compound in aqueous solution are significantly worse than in the organic solvents, for all the models. Indeed, for the NRTL-SAC models, the results for salicylamide in water are the worst out of all evaluated systems. In Figure 5 , the second set of bars shown for salicylamide includes only the organic solvents. If water is disregarded, the prediction results for salicylamide become much better, and for the NRTL-SAC models significantly more in line with the trend observed for the other compounds. No apparent difference in prediction accuracy is seen among the organic solvents. In Figure 6 , the RMSLE values in Figure 5 Within the framework of group contribution methods, the accuracy of the Pharma UNIFAC model depends on the determination of binary interaction parameters. These have been determined from correlations to large amounts of VLE and SLE data. Diedrichs and Gmehling 17 have shown that the Pharma UNIFAC model can outperform the original UNIFAC and the Modified UNIFAC (Do) models, but the results of this work indicate that there remains a need for further development of the UNIFAC models in order to enable prediction of the solubility of pharmaceuticals with acceptable accuracy. It should be kept in mind, however, that an important strength of the Pharma UNIFAC model is that basically no data needs to be experimentally determined for the particular compound. As regards the NRTL-SAC models, the prediction accuracy depends on the activity coefficient data used to calibrate the respective model. In this work, due to a lack of solubility data in sufficient numbers of chemically diverse solvents, we used only two solvents to determine segment numbers of the model pharmaceuticals. As such, the results obtained with these methods are suboptimal. Although even with this limitation both NRTL-SAC models did perform better overall than Pharma UNIFAC, we do expect the introduction of additional solvents for parametrization to improve the prediction capability. For the purpose of verifying this statement for one case, we have re-determined segment parameters of NRTL-SAC(T) for one of the compounds, salicylamide, but this time using data in four solvents (methanol, ethyl acetate, acetone and acetonitrile). Using the new segment parameters: rX = 0.610, rY-= 0.048, rY+ = 1.064
and rZ = 0.534, the RMSLE in predicted solubility in water was in fact significantly reduced, from 5.12 to 3.44.
On a final note, as a general hypothesis, we expect the significance of the temperature-dependence of the interaction parameters to be larger the wider the range of temperatures to be covered.
However, there is no apparent trend in relative performance between the models with increasing size of evaluated temperature range of experimental solubility data. In this work, with the exception of butamben (ΔT = 15 K), the temperature ranges are fairly similar for the evaluated systems, and in no case exceeds 45 K.
Conclusions
We have shown that introducing a simple inverse temperature-dependence to the binary interaction parameters of the NRTL-SAC activity coefficient model leads to an improvement in the performance of this model for correlation of vapor-liquid as well as solid-liquid equilibrium data.
Furthermore, the results show that, for prediction of the solubility of pharmaceutical compounds in organic solvents, the temperature-dependent form of NRTL-SAC results in an improvement in the accuracy over the original form of the model, while both models are more accurate than Pharma UNIFAC. For an evaluated set of pharmaceutical compounds, the accuracy of both NRTL-SAC models are shown to deteriorate with increasing solute molecular weight. The results stress the need for more work in order to develop predictive models with accuracy sufficient for process design.
Supporting information
Experimental determination of heat capacities of solid and melt of salicylamide by differential scanning calorimetry, together with correlation and calculation of ∆Cp as a function of temperature.
